Family Office Of America (FOFA) Income from Continuing Operations (2021 - 2026)
Family Office Of America's (FOFA) quarterly Income from Continuing Operations came in at 209049.0 in Q1 2026, up 302.33% year-on-year from 51959.63 in Q1 2025, and up 185.94% quarter-over-quarter from 243255.0 in Q4 2025.
Family Office Of America (FOFA) Income from Continuing Operations (2021 - 2026) Analysis & Trends
Family Office Of America has disclosed Income from Continuing Operations across 6 years of filings, most recently posting 209049.0 for Q1 2026.
- Income from Continuing Operations for Q1 2026 came in at 209049.0, up 302.33% year-over-year; the trailing twelve-month figure through Mar 2026 was 180378.0 (up 3.87% YoY), and the FY2025 annual result was 492748.0, down 390.37% from the prior year.
- Income from Continuing Operations came in at 209049.0 for Q1 2026 at Family Office Of America, up from 243255.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 943223.0 in Q4 2023 to a low of 1639861.0 in Q2 2023.
- The 5-year median for Income from Continuing Operations is 79811.0 (2023), against an average of 124101.12.
- Across the five-year window, Income from Continuing Operations surged 601.04% in 2023 and plunged 699.65% in 2025, its largest moves.
- Family Office Of America's Income from Continuing Operations stood at 188254.0 in 2022, then soared by 601.04% to 943223.0 in 2023, then tumbled by 103.23% to 30420.0 in 2024, then sank by 699.65% to 243255.0 in 2025, then surged by 185.94% to 209049.0 in 2026.
- The last three Income from Continuing Operations figures came in at 209049.0 (Q1 2026), 243255.0 (Q4 2025), and 50944.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 273.95 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 220.30 Mn |
| 10 | Family Office Of America | - | - | 783,126.00 | 209,049.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 209,049.00 |
| Dec 31, 2025 | -243,255.00 |
| Sep 30, 2025 | -50,944.00 |
| Jun 30, 2025 | -95,228.00 |
| Mar 31, 2025 | -103,321.00 |
| Dec 31, 2024 | -30,420.00 |
| Sep 30, 2024 | -22,676.00 |
| Jun 30, 2024 | -31,228.00 |
| Mar 31, 2024 | -16,160.00 |
| Dec 31, 2023 | 943,223.00 |
| Sep 30, 2023 | -28,572.00 |
| Jun 30, 2023 | -1.64 Mn |
| Mar 31, 2023 | -79,811.00 |
| Dec 31, 2022 | -188,254.00 |
| Sep 30, 2022 | -126,659.00 |
| Jun 30, 2022 | -510,529.00 |
| Mar 31, 2022 | -95,073.00 |
| Dec 31, 2021 | -386,442.00 |
| Sep 30, 2021 | -518,866.00 |
| Jun 30, 2021 | -622,777.00 |